Maccura Biotechnology Co (SZSE:300463) Other Operating Expense : ¥533 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co Other Operating Expense?

Maccura Biotechnology Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥533 Mil.

Maccura Biotechnology Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-234 Mil) to Dec. 2024 (¥533 Mil) but then declined from Dec. 2024 (¥533 Mil) to Mar. 2025 (¥0 Mil).

Maccura Biotechnology Co's annual Other Operating Expense increased from Dec. 2022 (¥480 Mil) to Dec. 2023 (¥485 Mil) and increased from Dec. 2023 (¥485 Mil) to Dec. 2024 (¥527 Mil).

Maccura Biotechnology Co Other Operating Expense Historical Data

The historical data trend for Maccura Biotechnology Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co Other Operating Expense Chart

Maccura Biotechnology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

375.05

433.45

479.74

484.58

527.21

Maccura Biotechnology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-5.41	233.25	-233.90	533.27	0.38

Maccura Biotechnology Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥533 Mil.

Maccura Biotechnology Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Maccura Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731

Website

https://www.maccura.com/

Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Executives

Guo Lei	Director
Wang Deng Ming	Directors, executives
Wang Lin	Supervisors
Wu Ming Jian	Directors, executives
Shi Wei	Directors, executives
Yang Hui	Supervisors
Zhou Yue Guo	Executives
Wang Zhen	Executives
Yu Ping	Executives
Zou Yuan	Supervisors
Xu Sheng Guo	Directors, executives
Liu Qi Lin	Directors, executives
Chu Jian Jun	Executives
Tang Yong	Director
Xu Jin Song	Executives

Maccura Biotechnology Co Headlines

No Headlines